EDAP - Rasio utang marang kapitalisasi buku edap-tms.com

Logo korporat perusahaan EDAP Medical (EDAP)

The debt-to-equity ratio helps assess the resilience of EDAP TMS S.A. (EDAP) to the slow adoption of HIFU therapy and associated training costs. Patent protection for Focal One strengthens market positioning, although certification across various countries is slowing expansion. The value of 2.64 serves as the current metric, enabling an analysis of the capital structure and the elimination of speculative distortions in the share price.

EDAP TMS SA - Utang-utang marang kapitalisasi buku EDAP (periode 04.07.2022 - 01.06.2026)
Barang unggulan EDAP TMS SA

Defensive assets are selected based on the resilience of their capital structure to external shocks. For EDAP TMS S.A. (EDAP), financial flexibility is critical due to a heavy reliance on external electronic component suppliers. This chart of the total debt-to-book capitalization ratio measures the proportion of borrowed funds relative to equity. An increasing ratio signals rising credit risk and vulnerability to compliance requirements, while a decrease in the metric confirms the business's financial autonomy and security.

Pesaing EDAP TMS S.A.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Utang-utang marang kapitalisasi buku|LUNG - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku telabio.com|CytoSorbents Corporation (CTSO) - Rasio utang marang nilai buku|SRTS: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Zynex Medical|Utang-utang marang kapitalisasi buku ECOR (electroCore, Inc.)|Utang marang nilai buku vicarioussurgical.com (RBOT)|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku